Meet The Startup Producing The First Prescription Nicotine Replacement In 20 Years

With $35 million in funding, Qnovia hopes its device will become the first new prescription nicotine replacement therapy in 20 years.

Six years ago, in a townhouse in Santa Monica, Mario Danek, began tinkering on a device to help cigarette smokers quit. After buying nebulizers, syringes, gaskets, battery packs, electrical firmware and pharmaceutical-grade nicotine liquid, Danek—who had recently sold his stake in a vaporizer company—took everything apart and hacked together a functional prototype.

Read the full story on Forbes: https://www.forbes.com/sites/willyako...

Subscribe to FORBES: https://www.youtube.com/user/Forbes?s...

Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:

https://account.forbes.com/membership...

Stay Connected
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter:   / forbes  
Forbes Video on Instagram:   / forbes  
More From Forbes: http://forbes.com

Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.